Table 3 Characteristics of glucocorticoid-induced osteoporosis patients with/without major osteoporotic and hip fractures
Variables | Major osteoporotic fracture (MOF) | Hip fracture (HF) | ||||||
|---|---|---|---|---|---|---|---|---|
With fracture (n = 32) | Without fracture (n = 191) | Mean difference (95%CI) | p-value | With fracture (n = 2) | Without fracture (n = 221) | Mean difference (95%CI) | p-value | |
T-score at L1-4 | -2.1 ± 1.44 | -1.55 ± 1.16 | -0.55 (-1.01, -0.09) | 0.019 | -2.9 ± 0.85 | -1.62 ± 1.21 | -1.28 (-2.97, 0.41) | 0.137 |
T-score at total hip | -2.12 ± 1.13 | -1.27 ± 0.95 | -0.85 (-1.22, -0.48) | < 0.001 | -4.35 ± 1.06 | -1.36 ± 0.98 | -2.99 (-4.37, -1.62) | < 0.001 |
T-score at FN | -2.63 ± 0.94 | -1.81 ± 0.88 | -0.82 (-1.16, -0.48) | < 0.001 | -3.6 ± 1.41 | -1.91 ± 0.92 | -1.69 (-2.98, -0.41) | 0.01 |
GC-FRAX with BMD, MOF (%) | 25.17 ± 11.57 | 10.53 ± 6.68 | 14.64 (10.37, 18.91) | < 0.001 | 34.4 ± 26.02 | 12.41 ± 8.73 | 21.99 (-21.82, 25.48) | 0.443 |
GC-FRAX with BMD, Hip (%) | 12.43 ± 8.71 | 4.24 ± 4.49 | 8.19 (4.99, 11.39) | < 0.001 | 24.28 ± 21.74 | 5.23 ± 5.56 | 19.05 (-17.83, 21.39) | 0.432 |
GC-FRAX without BMD, MOF (%) | 20.61 ± 7.49 | 9.01 ± 5.61 | 11.6 (9.38, 13.82) | < 0.001 | 17.9 ± 7.21 | 10.59 ± 7.14 | 7.31 (-2.68, 17.3) | 0.151 |
GC-FRAX without BMD, Hip (%) | 10.07 ± 6.25 | 3.66 ± 3.79 | 6.41 (4.1, 8.72) | < 0.001 | 12.04 ± 9.85 | 4.5 ± 4.69 | 7.53 (0.92, 14.15) | 0.026 |